P

Pierrel SpA
MIL:PRL

Watchlist Manager
Pierrel SpA
MIL:PRL
Watchlist
Price: 1.745 EUR
Market Cap: 95.9m EUR

Operating Margin
Pierrel SpA

10.8%
Current
12%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.8%
=
Operating Profit
3.5m
/
Revenue
33m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IT
Pierrel SpA
MIL:PRL
95.9m EUR
11%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
495.1B USD
27%
CH
Roche Holding AG
SIX:ROG
271.3B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
218.9B GBP
24%
US
Merck & Co Inc
NYSE:MRK
276.1B USD
38%
CH
Novartis AG
SIX:NOVN
218.1B CHF
33%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
143.8B USD
29%
No Stocks Found

Pierrel SpA
Glance View

Market Cap
95.9m EUR
Industry
Pharmaceuticals

Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. The company is headquartered in Capua, Caserta. The company went IPO on 2006-05-23. The firm specializes in the pharmaceutical research, development and the manufacture of medicines. The company operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. The company manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.

PRL Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.8%
=
Operating Profit
3.5m
/
Revenue
33m
What is the Operating Margin of Pierrel SpA?

Based on Pierrel SpA's most recent financial statements, the company has Operating Margin of 10.8%.

Back to Top